OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.

Most projects fail not due to a lack of talent but due to poor resource allocation. When your best people are double-booked and your supporting cast sits idle, no amount of methodology, new approaches ...